688131 皓元医药
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额159,008(63,606)(240,233)57,835116,789
投资活动产生之现金流量净额(179,205)(328,511)(713,002)(305,839)(74,161)
筹资活动产生之现金流量净额36,478409,209360,3241,007,29450,277
汇率变动对现金及现金等价物的影响4,2163,11114,415(7,242)(9,290)
现金及现金等价物净增加/(减少)20,49720,202(578,496)752,04783,616
期初现金及现金等价物余额475,466455,2641,033,760281,713198,097
期末现金及现金等价物余额495,963475,466455,2641,033,760281,713